Christo J.F. Muller
Chief Specialist Scientist
Biomedical Research and Innovation Platform (BRIP),
Prof Muller focuses his research on the potential role of phenolic compounds in the prevention and treatment of metabolic conditions such as insulin resistance, dysbiosis, obesity and type 2 diabetes. He is also involved with a proteomics study to identify early markers for type 2 diabetes. These markers are currently being tested in human subjects. He has 2 International patents (the USA and Europe) for the prevention of diabetes and has authored and co-authored 81 peer-reviewed articles and two book chapters.
Metabolic disease (pathophysiology, prevention, and treatment), phytotherapeutics and early detection of type 2 diabetes.